Insulin pump therapy for pregnancy: A primer

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 6, 2012, Pages 552-557

  Bernasko, James ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Continuous subcutaneous insulin infusion; Diabetes and pregnancy; Intensive insulin therapy; Preconception care

Indexed keywords

GLUCOSE; ISOPHANE INSULIN; PIG INSULIN; SHORT ACTING INSULIN;

BEDTIME DOSAGE; BLOOD GLUCOSE MONITORING; CONTINUOUS SUBCUTANEOUS INSULIN INFUSION; DIABETIC PATIENT; DRUG FORMULATION; GLUCOSE METABOLISM; HEALTH CARE PERSONNEL; HUMAN; HYPERGLYCEMIA; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INSULIN TREATMENT; MULTIPLE INJECTION THERAPY; PHYSICIAN; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DRUG DOSAGE CALCULATIONS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFUSION PUMPS; INSULIN; INSULIN INFUSION SYSTEMS; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 84861068478     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.598586     Document Type: Review

References (58)

1. Diabetes care and research in Europe: The Saint Vincent declaration. Diabet Med 1990;7:360.
2. Pregnancy outcomes in the diabetes control and complications trial. Am J Obstet Gynecol 1996;174:1343-1353.
3. Nordström L, Spetz E, Wallström K, Walinder O. Metabolic control and pregnancy outcome among women with insulin-dependent diabetes mellitus. A twelve-year follow-up in the country of Jämtland, Sweden. Acta Obstet Gynecol Scand 1998;77:284-289.
4. McElvy SS, Miodovnik M, Rosenn B, Khoury JC, Siddiqi T, Dignan PS, Tsang RC. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med 2000;9:14-20.
5. Wylie BR, Kong J, Kozak SE, Marshall CJ, Tong SO, Thompson DM. Normal perinatal mortality in type 1 diabetes mellitus in a series of 300 consecutive pregnancy outcomes. Am J Perinatol 2002;19: 169-176.
6. Platt MJ, Stanisstreet M, Casson IF, Howard CV, Walkinshaw S, Pennycook S, McKendrick O. St Vincent's Declaration 10 years on: Outcomes of diabetic pregnancies. Diabet Med 2002;19:216-220.
7. Penney GC, Mair G, Pearson DW; Scottish Diabetes in Pregnancy Group. Outcomes of pregnancies in women with type 1 diabetes in Scotland: A national population-based study. BJOG 2003;110: 315-318.
8. Dunne F, Brydon P, Smith K, Gee H. Pregnancy in women with type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med 2003;20: 743-748.
9. Vääräsmäki MS, Hartikainen A, Anttila M, Pramila S, Koivisto M. Factors predicting peri-and neonatal outcome in diabetic pregnancy. Early Hum Dev 2000;59:61-70.
10. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: Nationwide prospective study in the Netherlands. BMJ 2004;328:915.
11. Sharpe PB, Chan A, Haan EA, Hiller JE. Maternal diabetes and congenital anomalies in South Australia 1986-2000: A population-based cohort study. Birth Defects Res Clin Mol teratol 2005;73;605-611.
12. Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M, Beck-Nielsen H. Outcomes in type 1 diabetic pregnancies: A nationwide, population-based study. Diabetes Care 2004;27:2819-2823.
13. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518-524.
14. The Diabetic Control and Complications Trial Research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
15. The United Kingdom Prospective Diabetes Study Research Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and the risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-853.
16. Hiéronimus S, Cupelli C, Bongain A, Durand-Réville M, Berthier F, Fénichel P. [Pregnancy in type 1 diabetes: Insulin pump versus intensified conventional therapy]. Gynecol Obstet Fertil 2005;33: 389-394.
17. Lepercq J. [Pregnancy in type 1 diabetes: Insulin pump versus intensified conventional therapy. Gynecol Obstet Fertil 2005;33:389-394]. Gynecol Obstet Fertil 2005;33:955-956.
18. Gabbe SG, Holing E, Temple P, Brown ZA. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 2000;182:1283-1291.
19. Lapolla A, Dalfrà MG, Masin M, Bruttomesso D, Piva I, Crepaldi C, Tortul C, et al. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy. Acta Diabetol 2003;40:143-149.
20. Giménez M, Conget I, Nicolau J, Pericot A, Levy I. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study. Acta Diabetol 2007;44:34-37.
21. Volpe L, Pancani F, Aragona M, Lencioni C, Battini L, Ghio A, Resi V, et al. Continuous subcutaneous insulin infusion and multiple dose insulin injections in Type 1 diabetic pregnant women: A case-control study. Gynecol Endocrinol 2010;26:193-196.
22. González-Romero S, González-Molero I, Fernández- Abellán M, Domínguez-López ME, Ruiz-de-Adana S, Olveira G, Soriguer F. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes. Diabetes Technol Ther 2010;12:263-269.
23. Chen R, Ben-Haroush A, Weismann-Brenner A, Weissman-Brenner A, Melamed N, Hod M, Yogev Y. Level of glycemic control and pregnancy outcome in type 1 diabetes: A comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions. Am J Obstet Gynecol 2007;197:404.e1-404.e5.
24. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: A meta-analysis. Diabetes Care 2003;26:1079-1087.
25. Farrar D, Tuffnell DJ, West J. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev 2007;3:CD005542.
26. Mukhopadhyay A, Farrell T, Fraser RB, Ola B. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: A systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 2007;197:447-456.
27. Bernasko J. A practical guide to insulin pump therapy for pregnancy. IUniverse Publishing Company. 2010.
28. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: A meta-analysis. QJM 2001;94:435-444.
29. Kalkhoff RK, Kissebah AH, Kim HJ. Carbohydrate and lipid metabolism during normal pregnancy: Relationship to gestational hormone action. Semin Perinatol 1978;2:291-307.
30. Kalkhoff RK, Richardson BL, Beck P. Relative effects of pregnancy, human placental lactogen and prednisolone on carbohydrate tolerance in normal and subclinical diabetic subjects. Diabetes 1969;18:153-163.
31. Samaan N, Yen SC, Gonzalez D, Pearson OH. Metabolic effects of placental lactogen (HPL) in man. J Clin Endocrinol Metab 1968;28:485-491.
32. Burke CW, Roulet F. Increased exposure of tissues to cortisol in late pregnancy. Br Med J 1970;1:657-659.
33. Gustafson AB, Banasiak MF, Kalkhoff RK, Hagen TC, Kim HJ. Correlation of hyperprolactinemia with altered plasma insulin and glucagon: Similarity to effects of late human pregnancy. J Clin Endocrinol Metab 1980;51:242-246.
34. Lepore G, Dodesini AR, Nosari I, Trevisan R. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment. Diabetes Care 2003;26:1321-1322.
35. Simmons D, Thompson CF, Conroy C, Scott DJ. Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community. Diabetes Care 2001;24:2078-2082.
36. Chase HP, Saib SZ, MacKenzie T, Hansen MM, Garg SK. Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes. Diabet Med 2002;19:317-321.
37. Henriksen JE, Djurhuus MS, Vaag A, Thye-Rønn P, Knudsen D, Hother-Nielsen O, Beck-Nielsen H. Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen. Diabetologia 1993;36:752-758.
38. Bode BW. Pumping protocol. A physician's guide to insulin pump therapy initiation. 1997. Minimed Inc. Publication.
39. Heinemann L, Weyer C, Rauhaus M, Heinrichs S, Heise T. Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart. Diabetes Care 1998;21:1910-1914.
40. Anderson JH Jr, Brunelle RL, Koivisto VA, Pfützner A, Trautmann ME, Vignati L, DiMarchi R. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. Diabetes 1997;46: 265-270.
41. Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T. Insulin lispro in CSII: Results of a double-blind crossover study. Diabetes 1997;46:440-443.
42. Mathiesen ER, Kinsley B, Amiel SA, Heller S, McCance D, Duran S, Bellaire S, Raben A; Insulin Aspart Pregnancy Study Group. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: A randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007;30:771-776.
43. Brunelle BL, Llewelyn J, Anderson JH Jr, Gale EA, Koivisto VA. Metaanalysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 1998;21:1726-1731.
44. Homko C, Deluzio A, Jimenez C, Kolaczynski JW, Boden G. Comparison of insulin aspart and lispro: Pharmacokinetic and metabolic effects. Diabetes Care 2003;26:2027-2031.
45. Hedman CA, Lindström T, Arnqvist HJ. Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes. Diabetes Care 2001;24:1120-1121.
46. Boskovic R, Feig DS, Derewlany L, Knie B, Portnoi G, Koren G. Transfer of insulin lispro across the human placenta: In vitro perfusion studies. Diabetes Care 2003;26:1390-1394.
47. Hellmuth E, Damm P, Mølsted-Pedersen L, Bendtson I. Prevalence of nocturnal hypoglycemia in first trimester of pregnancy in patients with insulin treated diabetes mellitus. Acta Obstet Gynecol Scand 2000;79:958-962.
48. Evert AB, Mauseth RS. The new insulin analogs: Using a team approach to implement basal-bolus therapy. Practical Diabetology 2004;23:28-37.
49. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes control and complications trial. Diabetes 1997;46:271-286.
50. Kimmerle R, Heinemann L, Delecki A, Berger M. Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women. Diabetes Care 1992;15:1034-1037.
51. Rosenn BM, Miodovnik M, Holcberg G, Khoury JC, Siddiqi TA. Hypoglycemia: The price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 1995;85:417-422.
52. Evers IM, ter Braak EW, de Valk HW, van Der Schoot B, Janssen N, Visser GH. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. Diabetes Care 2002;25:554-559.
53. Hellmuth E, Damm P, Mølsted-Pedersen L, Bendtson I. Prevalence of nocturnal hypoglycemia in first trimester of pregnancy in patients with insulin treated diabetes mellitus. Acta Obstet Gynecol Scand 2000;79:958-962.
54. ter Braak EW, Evers IM, Willem Erkelens D, Visser GH. Maternal hypoglycemia during pregnancy in type 1 diabetes: Maternal and fetal consequences. Diabetes Metab Res Rev 2002;18:96-105.
55. Salvesen DR, Freeman J, Brudenell JM, Nicolaides KH. Prediction of fetal acidaemia in pregnancies complicated by maternal diabetes mellitus by biophysical profile scoring and fetal heart rate monitoring. Br J Obstet Gynaecol 1993;100:227-233.
56. Kontopoulos EV, Vintzileos AM. Condition-specific antepartum fetal testing. Am J Obstet Gynecol 2004;191:1546-1551.
57. Kline GA, Edwards A. Antepartum and intra-partum insulin management of type 1 and type 2 diabetic women: Impact on clinically significant neonatal hypoglycemia. Diabetes Res Clin Pract 2007;77:223-230.
58. Mayer-Davis EJ, Rifas-Shiman SL, Zhou L, Hu FB, Colditz GA, Gillman MW. Breast-feeding and risk for childhood obesity: Does maternal diabetes or obesity status matter? Diabetes Care 2006;29:2231-2237.